<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Organic chemistry CYP2C9 Losartan Tienilic acid CYP2D6 Diclofenac Microsome CYP2C19 CYP2C8 Cytochrome P450 Chemistry Biology |
| ProCube® W_CYP2C9(b5) recombinant human CYP2C9 (+b5) microsomesDocID: 1ui1a - View Document |
| Impact of Concomitant Antiretrovirals, and CYP2C9 and CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine 1 2DocID: 1omXF - View Document |
| Chapter 4. Pharmacogenetics and Pharmacogenomics Kim Brøsen, M.D., Ph.D. Institute of Public Health Clinical Pharmacology University of Southern DenmarkDocID: 1aYno - View Document |
| CYP2C9 CYP2C9 Genotype2 nmd4 nmd nmdDocID: 18mo5 - View Document |
| CYP2C9 and VKORC11 CYP2C9 2 VKORC1DocID: 180Qn - View Document |